TrialDrug design, development and therapy2025
Effects of Food on the Pharmacokinetics and Safety of HA121-28 Tablet, a Novel Multi-Targeting Tyrosine Kinase Inhibitor, in Healthy Chinese Subjects: A Phase I Clinical Trial.
Yixian Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.